ID   SCYL2_HUMAN             Reviewed;         929 AA.
AC   Q6P3W7; A8KAB5; Q96EF4; Q96ST4; Q9H7V5; Q9NVH3; Q9P2I7;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-NOV-2010, entry version 71.
DE   RecName: Full=SCY1-like protein 2;
DE   AltName: Full=Coated vesicle-associated kinase of 104 kDa;
GN   Name=SCYL2; Synonyms=CVAK104, KIAA1360;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-357.
RC   TISSUE=Teratocarcinoma, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Carcinoma, and Leiomyosarcoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 138-929.
RC   TISSUE=Brain;
RX   MEDLINE=20181126; PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   FUNCTION, INTERACTION WITH CLATHRIN AND AP2 COMPLEX,
RP   AUTOPHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=15809293; DOI=10.1074/jbc.M502462200;
RA   Conner S.D., Schmid S.L.;
RT   "CVAK104 is a novel poly-L-lysine-stimulated kinase that targets the
RT   beta2-subunit of AP2.";
RL   J. Biol. Chem. 280:21539-21544(2005).
RN   [6]
RP   FUNCTION, INTERACTION WITH CLATHRIN AND AP2 COMPLEX, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16914521; DOI=10.1091/mbc.E06-05-0390;
RA   Duewel M., Ungewickell E.J.;
RT   "Clathrin-dependent association of CVAK104 with endosomes and the
RT   trans-Golgi network.";
RL   Mol. Biol. Cell 17:4513-4525(2006).
RN   [7]
RP   INTERACTION WITH AP2B1.
RX   PubMed=16903783; DOI=10.1371/journal.pbio.0040262;
RA   Schmid E.M., Ford M.G.J., Burtey A., Praefcke G.J.K., Peak-Chew S.-Y.,
RA   Mills I.G., Benmerah A., McMahon H.T.;
RT   "Role of the AP2 beta-appendage hub in recruiting partners for
RT   clathrin-coated vesicle assembly.";
RL   PLoS Biol. 4:E262-E262(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-438; THR-440 AND
RP   SER-677, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-357; SER-720 AND HIS-863.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of AP2-containing clathrin coated structures
CC       at the plasma membrane or of endocytic coated vesicles. According
CC       to PubMed:15809293, probable serine/threonine-protein kinase that
CC       phosphorylates, in vitro, the beta2-subunit of the plasma membrane
CC       adapter complex AP2 and other proteins in presence of poly-L-
CC       lysine. According to PubMed:16914521, has no detectable kinase
CC       activity in vitro. May regulate clathrin-dependent trafficking
CC       between the TGN and/or the endosomal system.
CC   -!- SUBUNIT: Interacts with clathrin and AP2B1; the interaction
CC       mediates the association with the AP-2 complex.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Cytoplasmic
CC       vesicle, clathrin-coated vesicle. Golgi apparatus, trans-Golgi
CC       network membrane. Endosome membrane. Note=According to
CC       PubMed:15809293, plasma membrane-associated in clathrin-coated
CC       vesicles. According to PubMed:16914521, colocalizes to the trans-
CC       Golgi network (TGN) and to endosomal membranes with clathrin,
CC       transferrin and plasma membrane adapter AP1 and AP3 complexes.
CC   -!- PTM: According to PubMed:15809293, autophosphorylated in presence
CC       of poly-L-lysine.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC   -!- SIMILARITY: Contains 1 HEAT repeat.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91778.1; Type=Erroneous initiation;
CC       Sequence=BAB14869.1; Type=Erroneous initiation;
CC       Sequence=BAB55194.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001597; BAA91778.1; ALT_INIT; mRNA.
DR   EMBL; AK024274; BAB14869.1; ALT_INIT; mRNA.
DR   EMBL; AK027551; BAB55194.1; ALT_INIT; mRNA.
DR   EMBL; AK292980; BAF85669.1; -; mRNA.
DR   EMBL; CH471054; EAW97633.1; -; Genomic_DNA.
DR   EMBL; BC012387; AAH12387.3; -; mRNA.
DR   EMBL; BC063798; AAH63798.1; -; mRNA.
DR   EMBL; AB037781; BAA92598.1; -; mRNA.
DR   IPI; IPI00396218; -.
DR   RefSeq; NP_060458.3; -.
DR   UniGene; Hs.506481; -.
DR   ProteinModelPortal; Q6P3W7; -.
DR   SMR; Q6P3W7; 48-361.
DR   IntAct; Q6P3W7; 6.
DR   MINT; MINT-1181355; -.
DR   STRING; Q6P3W7; -.
DR   PhosphoSite; Q6P3W7; -.
DR   PRIDE; Q6P3W7; -.
DR   Ensembl; ENST00000360820; ENSP00000354061; ENSG00000136021.
DR   GeneID; 55681; -.
DR   KEGG; hsa:55681; -.
DR   UCSC; uc001thn.1; human.
DR   CTD; 55681; -.
DR   GeneCards; GC12P100661; -.
DR   H-InvDB; HIX0010917; -.
DR   HGNC; HGNC:19286; SCYL2.
DR   HPA; HPA021050; -.
DR   PharmGKB; PA134887807; -.
DR   eggNOG; prNOG18614; -.
DR   HOGENOM; HBG446307; -.
DR   HOVERGEN; HBG055627; -.
DR   InParanoid; Q6P3W7; -.
DR   OMA; PDADQMT; -.
DR   OrthoDB; EOG9FBMC7; -.
DR   PhylomeDB; Q6P3W7; -.
DR   NextBio; 60474; -.
DR   ArrayExpress; Q6P3W7; -.
DR   Bgee; Q6P3W7; -.
DR   CleanEx; HS_SCYL2; -.
DR   Genevestigator; Q6P3W7; -.
DR   GermOnline; ENSG00000136021; Homo sapiens.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Endosome; Golgi apparatus; Membrane; Phosphoprotein; Polymorphism.
FT   CHAIN         1    929       SCY1-like protein 2.
FT                                /FTId=PRO_0000252446.
FT   DOMAIN       32    327       Protein kinase.
FT   REPEAT      443    479       HEAT.
FT   REGION      699    929       Necessary for interaction with AP2
FT                                complex and clathrin, interaction with
FT                                clathrin is necessary for its targeting
FT                                to the TGN and endosomal membranes.
FT   COILED      661    701       Potential.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     438    438       Phosphothreonine.
FT   MOD_RES     440    440       Phosphothreonine.
FT   MOD_RES     677    677       Phosphoserine.
FT   VARIANT     357    357       P -> L (in dbSNP:rs33968174).
FT                                /FTId=VAR_041368.
FT   VARIANT     720    720       T -> S.
FT                                /FTId=VAR_041369.
FT   VARIANT     863    863       Q -> H (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041370.
FT   CONFLICT    139    145       PISPDIK -> LMSGDIG (in Ref. 4; BAA92598).
FT   CONFLICT    186    186       L -> S (in Ref. 1; BAB14869).
FT   CONFLICT    424    424       Q -> QASNM (in Ref. 4; BAA92598).
FT   CONFLICT    439    439       K -> R (in Ref. 1; BAB14869).
FT   CONFLICT    554    554       F -> L (in Ref. 3; AAH12387).
FT   CONFLICT    628    628       Q -> R (in Ref. 1; BAB14869).
FT   CONFLICT    638    638       T -> I (in Ref. 3; AAH12387).
FT   CONFLICT    747    747       T -> A (in Ref. 1; BAA91778).
SQ   SEQUENCE   929 AA;  103709 MW;  980B481BF7044628 CRC64;
     MESMLNKLKS TVTKVTADVT SAVMGNPVTR EFDVGRHIAS GGNGLAWKIF NGTKKSTKQE
     VAVFVFDKKL IDKYQKFEKD QIIDSLKRGV QQLTRLRHPR LLTVQHPLEE SRDCLAFCTE
     PVFASLANVL GNWENLPSPI SPDIKDYKLY DVETKYGLLQ VSEGLSFLHS SVKMVHGNIT
     PENIILNKSG AWKIMGFDFC VSSTNPSEQE PKFPCKEWDP NLPSLCLPNP EYLAPEYILS
     VSCETASDMY SLGTVMYAVF NKGKPIFEVN KQDIYKSFSR QLDQLSRLGS SSLTNIPEEV
     REHVKLLLNV TPTVRPDADQ MTKIPFFDDV GAVTLQYFDT LFQRDNLQKS QFFKGLPKVL
     PKLPKRVIVQ RILPCLTSEF VNPDMVPFVL PNVLLIAEEC TKEEYVKLIL PELGPVFKQQ
     EPIQILLIFL QKMDLLLTKT PPDEIKNSVL PMVYRALEAP SIQIQELCLN IIPTFANLID
     YPSMKNALIP RIKNACLQTS SLAVRVNSLV CLGKILEYLD KWFVLDDILP FLQQIPSKEP
     AVLMGILGIY KCTFTHKKLG ITKEQLAGKV LPHLIPLSIE NNLNLNQFNS FISVIKEMLN
     RLESEHKTKL EQLHIMQEQQ KSLDIGNQMN VSEEMKVTNI GNQQIDKVFN NIGADLLTGS
     ESENKEDGLQ NKHKRASLTL EEKQKLAKEQ EQAQKLKSQQ PLKPQVHTPV ATVKQTKDLT
     DTLMDNMSSL TSLSVSTPKS SASSTFTSVP SMGIGMMFST PTDNTKRNLT NGLNANMGFQ
     TSGFNMPVNT NQNFYSSPST VGVTKMTLGT PPTLPNFNAL SVPPAGAKQT QQRPTDMSAL
     NNLFGPQKPK VSMNQLSQQK PNQWLNQFVP PQGSPTMGSS VMGTQMNVIG QSAFGMQGNP
     FFNPQNFAQP PTTMTNSSSA SNDLKDLFG
//
